Towards Characterization of Skin Melanoma in the Clinic by Electron Paramagnetic Resonance (EPR) Spectroscopy and Imaging of Melanin.

Cancer Clinical EPR EPR ESR In vivo Low frequency Melanin Melanoma Mice Patients

Journal

Molecular imaging and biology
ISSN: 1860-2002
Titre abrégé: Mol Imaging Biol
Pays: United States
ID NLM: 101125610

Informations de publication

Date de publication:
30 Jun 2023
Historique:
received: 28 04 2023
accepted: 23 06 2023
revised: 05 06 2023
medline: 30 6 2023
pubmed: 30 6 2023
entrez: 30 6 2023
Statut: aheadofprint

Résumé

The incidence of melanoma is continuously increasing over time. Melanoma is the most aggressive skin cancer, significantly reducing quality of life and survival rates of patients at advanced stages. Therefore, early diagnosis remains the key to change the prognosis of patients with melanoma. In this context, advanced technologies are under evaluation to increase the accuracy of the diagnostic, to better characterize the lesions and visualize their possible invasiveness in the epidermis. Among the innovative methods, because melanin is paramagnetic, clinical low frequency electron paramagnetic resonance (EPR) that characterizes the melanin content in the lesion has the potential to be an adjunct diagnostic method of melanoma. In this review, we first summarize the challenges faced by dermatologists and oncologists in melanoma diagnostic and management. We also provide a historical perspective on melanin detection with a focus on EPR spectroscopy/imaging of melanomas. We describe key elements that allow EPR to move from in vitro studies to in vivo and finally to patients for melanoma studies. Finally, we provide a critical view on challenges to meet to make EPR operational in the clinic to characterize pigmented lesions.

Identifiants

pubmed: 37389709
doi: 10.1007/s11307-023-01836-3
pii: 10.1007/s11307-023-01836-3
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fonds De La Recherche Scientifique - FNRS
ID : 2.5010.12
Organisme : Fonds De La Recherche Scientifique - FNRS
ID : U.N029.21
Organisme : Fondation contre le Cancer
ID : 2020-105

Informations de copyright

© 2023. The Author(s).

Références

Halpern AC, Marghoob AA, Sober AJ, Mar V, Marchetti MA (2020) Clinical presentations of melanoma. In: Balch CM et al (eds) Cutaneous Melanoma, 6th edn. Springer, pp 108–145
Dinnes J, Deeks JJ, Chuchu N et al (2018) Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults. Cochrane Database Syst Rev 12(12):CD011902
pubmed: 30521682
Dinnes J, Deeks JJ, Grainge MJ et al (2018) Visual inspection for diagnosing cutaneous melanoma in adults. Cochrane Database Syst Rev 12(12):CD013194
pubmed: 30521684
Piccolo D, Ferrari A, Peris K, Daidone R, Ruggeri B, Chimenti S (2002) Dermoscopic diagnosis by a trained clinician vs. a clinician with minimal dermoscopy training vs. computer-aided diagnosis of 341 pigmented skin lesions: A comparative study. Br J Dermatol 147(3):481–486
pubmed: 12207587
Calzavara-Pinton P, Longo C, Venturini M, Sala R, Pellacani G (2008) Reflectance confocal microscopy for in vivo skin imaging. Photochem Photobiol 84(6):1421–1430
pubmed: 19067964
Dinnes J, Deeks JJ, Saleh D et al (2018) Reflectance confocal microscopy for diagnosing cutaneous melanoma in adults. Cochrane Database Syst Rev 12(12):CD013190
pubmed: 30521681
Varkentin A, Mazurenka M, Blumenröther E, Meinhardt-Wollweber M, Rahlves M, Broekaert SMC, Schäd-Trcka S, Emmertinst S, Morgner U, Roth B (2017) Comparative study of presurgical skin infiltration depth measurements of melanocytic lesions with OCT and high frequency ultrasound. J Biophotonics 10(6-7):854–861
pubmed: 28009131
Ferrante di Ruffano L, Dinnes J, Deeks JJ, Chuchu N, Bayliss SE, Davenport C, Takwoingi Y, Godfrey K, O'Sullivan C, Matin RN, Tehrani H, Williams HC (2018) Cochrane Skin Cancer Diagnostic Test Accuracy Group. Optical coherence tomography for diagnosing skin cancer in adults. Cochrane Database Syst Rev 12(12):CD013189
pubmed: 30521690
Bobos M (2021) Histopathologic classification and prognostic factors of melanoma: A 2021 update. Ital. J. Dermatol. Venereol 156(3):300–321
Riley PA (1997) Melanin. Int J Biochem Cell Biol 29(11):1235–1239
pubmed: 9451820
Sarna T, Plonka PM (2005) Biophysical studies of melanin. In: Eaton SR, Eaton GR, Berliner LJ (eds) Biomedical EPR, Part A: Free Radicals, Metals, Medicine, and Physiology, Biological Magnetic Resonance, vol 23. Springer, Boston, MA, pp 125–146
Ito S, Wakamatsu K (2008) Chemistry of mixed melanogenesis--pivotal roles of dopaquinone. Photochem Photobiol 84(3):582–592
pubmed: 18435614
Sealy RC, Hyde JS, Felix CC, Menon IA, Prota G (1982) Eumelanins and pheomelanins: characterization by electron spin resonance spectroscopy. Sci 217(4559):545–547
Enochs WS, Nilges MJ, Swartz HM (1993) A standardized test for the identification and characterization of melanins using electron paramagnetic resonance (EPR) spectroscopy. Pigment Cell Res 6(2):91–99
pubmed: 8391699
Commoner B, Townsend J, Pake GE (1954) Free radicals in biological materials. Nature 174(4432):689–691
pubmed: 13213980
Mason HS, Ingram DJ, Allen B (1960) The free radical property of melanins. Arch. Biochem. Biophys 86:225–230
pubmed: 14422053
Nebert DW, Mason HS (1963) An electron spin resonance study of neoplasms. Cancer Res 23:833–840
pubmed: 14085278
Elek G, Lapis K, Rockenbauer A (1980) ESR investigation of paraffin-embedded ocular melanomas. Br J Cancer 41:199–203
pubmed: 6245671 pmcid: 2010198
Plonka PM, Slominski AT, Pajak S, Urbanska K (2003) Transplantable melanomas in gerbils (Meriones unguiculatus). II: melanogenesis. Exp Dermatol 12(4):356–364
pubmed: 12930290
Giuliano AE, Cochran AJ, Morton DL (1982) Melanoma from unknown primary site and amelanotic melanoma. Semin Oncol 9(4):442–444
pubmed: 7170630
Sarna T, Swartz HM, Zadlo A (2022) Interaction of melanin with metal ions modulates their cytotoxic potential. Appl Magn Reson 53:105–121
Katsuda H, Kobayashi T, Saito H, Matsunaga T, Ikeya M (1990) Electron spin resonance imaging of mouse B16 melanoma. Chem Pharm Bull 38(10):2838–2840
Vanea E, Charlier N, Dewever J, Dinguizli M, Feron O, Baurain JF, Gallez B (2008) Molecular electron paramagnetic resonance imaging of melanin in melanomas: a proof-of-concept. NMR Biomed 21(3):296–300
pubmed: 18246539
Godechal Q, Defresne F, Danhier P, Leveque P, Porporato PE, Sonveaux P, Baurain JF, Feron O, Gallez B (2011) Assessment of melanoma extent and melanoma metastases invasion using electron paramagnetic resonance and bioluminescence imaging. Contrast Media Mol Imaging 6(4):282–288
pubmed: 21861288
Godechal Q, Leveque P, Marot L, Baurain JF, Gallez B (2012) Optimization of electron paramagnetic resonance imaging for visualization of human skin melanoma in various stages of invasion. Exp Dermatol 21(5):341–346
pubmed: 22509830
Godechal Q, Ghanem GE, Cook MG, Gallez B (2013) Electron paramagnetic resonance spectrometry and imaging in melanomas: comparison between pigmented and nonpigmented human malignant melanomas. Mol Imaging 12(4):218–223
pubmed: 23651499
Schreiber WA, Petryakov S, Kmiec MM, Flood AB, Swartz HM, Schaner PE, Williams BB (2022) In vivo CW-EPR spectrometer systems for dosimetry and oximetry in preclinical and clinical applications. Appl Magn Reson 53:123–143
Hirata H, Swartz HM (2022) RF/microwave resonators for preclinical and clinical EPR applications: current status and challenges. Appl Magn Reson 53:167–191
Swartz HM (2016) Using stable free radicals to obtain unique and clinically useful data in vivo in human subjects. Radiat Prot Dosimetry 172(1-3):3–15
pubmed: 27886997 pmcid: 6061194
Flood AB, Wood VA, Schreiber W, Williams BB, Gallez B, Swartz HM (2018) Guidance to transfer ‘Bench-Ready’ medical technology into usual clinical practice: case study - sensors and spectrometer used in EPR oximetry. Adv Exp Med Biol 1072:233–239
pubmed: 30178351 pmcid: 6126358
Schaner PE, Williams BB, Chenet EY, Pettus JR, Schreiber WA, Kmiec MM, Jarvis LA, Pastel DA, Zuurbier RA, DiFlorio-Alexander RM, Paydarfar JA, Gosselin BJ, Barth RJ, Rosenkranz KM, Petryakov SV, Hou H, Tse D, Pletnev A, Flood AB et al (2021) First-in-human study in cancer patients establishing the feasibility of oxygen measurements in tumors using electron paramagnetic resonance with the OxyChip. Front Oncol 11:743256
pubmed: 34660306 pmcid: 8517507
Desmet CM, Danhier P, Acciardo S, Levêque P, Gallez B (2019) Towards in vivo melanin radicals detection in melanomas by electron paramagnetic resonance (EPR) spectroscopy: a proof-of-concept study. Free Radic Res 53(4):405–410
pubmed: 30864859
Cesareo E, Korkina L, D'Errico G, Vitiello G, Aguzzi MS, Passarelli F, Pedersen JZ, Facchiano A (2012) An endogenous electron spin resonance (ESR) signal discriminates nevi from melanomas in human specimens: a step forward in its diagnostic application. PLoS One 7(11):e48849
pubmed: 23144997 pmcid: 3492252
Mignion L, Desmet CM, Harkemanne E, Tromme I, Joudiou N, Wehbi M, Baurain JF, Gallez B (2022) Noninvasive detection of the endogenous free radical melanin in human skin melanomas using electron paramagnetic resonance (EPR). Free Radic Biol Med 190:226–233
pubmed: 35987421
Williams BB, Dong R, Flood AB, Grinberg O, Kmiec M, Lesniewski PN, Matthews TP, Nicolalde RJ, Raynolds T, Salikhov IK, Swartz HM (2011) A deployable in vivo EPR tooth dosimeter for triage after a radiation event involving large populations. Radiat Meas 46(9):772–777
pubmed: 21966241 pmcid: 3182096
Miyake M, Nakai Y, Yamaguchi I, Hirata H, Kunugita N, Williams BB, Swartz HM (2016) In-vivo radiation dosimetry using portable L Band EPR: on-site measurement of volunteers in Fukushima prefecture. Japan. Radiat Prot Dosimetry 172(1-3):248–253
pubmed: 27522046
Gonet M, Baranowski M, Czechowski T, Kucinska M, Plewinski A, Szczepanik P, Jurga S, Murias M (2020) Multiharmonic electron paramagnetic resonance imaging as an innovative approach for in vivo studies. Free Radic Biol Med. 152:271–279
pubmed: 32222471
Eaton SS, Shi Y, Woodcock L, Buchanan LA, McPeak J, Quine RW, Rinard GA, Epel B, Halpern HJ, Eaton GR (2017) Rapid-scan EPR imaging. J Magn Reson 280:140–148
pubmed: 28579099 pmcid: 5523658
Tseytlin O, Guggilapu P, Bobko AA, AlAhmad H, Xu X, Epel B, O'Connell R, Hoblitzell EH, Eubank TD, Khramtsov VV, Driesschaert B, Kazkaz E, Tseytlin M (2019) Modular imaging system: rapid scan EPR at 800 MHz. J Magn Reson 305:94–103
pubmed: 31238278 pmcid: 6656609
Petryakov S, Chzhan M, Samouilov A, He G, Kuppusamy P, Zweier JL (2001) A bridged loop-gap S-band surface resonator for topical EPR spectroscopy. J Magn Reson 151(1):124–128
pubmed: 11444946
Schreiber W, Petryakov SV, Kmiec MM, Feldman MA, Meaney PM, Wood VA, Boyle HK, Flood AB, Williams BB, Swartz HM (2016) Flexible, wireless, inductively coupled surface coil resonator for EPR tooth dosimetry. Radiat Protect Dosim 172:87–95
Slominski RM, Sarna T, Płonka PM, Raman C, Brożyna AA, Slominski AT (2022) Melanoma, melanin, and melanogenesis: the Yin and Yang relationship. Front Oncol 14(12):842496
Wakamatsu K, Zippin JH, Ito S (2021) Chemical and biochemical control of skin pigmentation with special emphasis on mixed melanogenesis. Pigment Cell Melanoma Res 34(4):730–747
pubmed: 33751833 pmcid: 8861806

Auteurs

Mohammad Wehbi (M)

Biomedical Magnetic Resonance Research Group, Louvain Drug Research Institute, Université catholique de Louvain (UCLouvain), Avenue Mounier 73.08, B -, 1200, Brussels, Belgium.

Evelyne Harkemanne (E)

Department of Dermatology, Melanoma Clinic, King Albert II Institute, St Luc Hospital, Université catholique de Louvain (UCLouvain), Brussels, Belgium.

Lionel Mignion (L)

Nuclear and Electron Spin Technologies (NEST) Platform, Louvain Drug Research Institute, |Université catholique de Louvain (UCLouvain), Brussels, Belgium.

Nicolas Joudiou (N)

Nuclear and Electron Spin Technologies (NEST) Platform, Louvain Drug Research Institute, |Université catholique de Louvain (UCLouvain), Brussels, Belgium.

Isabelle Tromme (I)

Department of Dermatology, Melanoma Clinic, King Albert II Institute, St Luc Hospital, Université catholique de Louvain (UCLouvain), Brussels, Belgium.

Jean-François Baurain (JF)

Department of Oncology, Melanoma Clinic, King Albert II Institute, St Luc Hospital, Université catholique de Louvain (UCLouvain), Brussels, Belgium.

Bernard Gallez (B)

Biomedical Magnetic Resonance Research Group, Louvain Drug Research Institute, Université catholique de Louvain (UCLouvain), Avenue Mounier 73.08, B -, 1200, Brussels, Belgium. bernard.gallez@uclouvain.be.
Nuclear and Electron Spin Technologies (NEST) Platform, Louvain Drug Research Institute, |Université catholique de Louvain (UCLouvain), Brussels, Belgium. bernard.gallez@uclouvain.be.

Classifications MeSH